Clinical Trial Update: S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry updates the Phase 3 S1602 study evaluating different strains of Bacillus Calmette-Guérin (BCG) with or without vaccine for high-gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Stage 0 Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING